EBR Systems, Inc.

ASX:EBR Stock Report

Market Cap: AU$171.2m

EBR Systems Valuation

Is EBR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of EBR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: EBR (A$0.38) is trading below our estimate of future cash flow value (A$5.63)

Significantly Below Future Cash Flow Value: EBR is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EBR?

Key metric: As EBR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for EBR. This is calculated by dividing EBR's market cap by their current revenue.
What is EBR's PS Ratio?
PS Ratio30.7x
SalesUS$3.98m
Market CapUS$122.26m

Price to Sales Ratio vs Peers

How does EBR's PS Ratio compare to its peers?

The above table shows the PS ratio for EBR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average22.5x
AHC Austco Healthcare
0.9x6.54%AU$84.3m
OIL Optiscan Imaging
60xn/aAU$146.2m
SOM SomnoMed
1.1x8.62%AU$131.4m
EMV EMVision Medical Devices
28.1x17.89%AU$152.4m
EBR EBR Systems
30.7x44.88%AU$171.2m

Price-To-Sales vs Peers: EBR is expensive based on its Price-To-Sales Ratio (30.7x) compared to the peer average (22.5x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does EBR's PS Ratio compare vs other companies in the AU Medical Equipment Industry?

17 CompaniesPrice / SalesEstimated GrowthMarket Cap
ANN Ansell
1.4x3.90%US$2.76b
SDI SDI
1.4xn/aUS$115.44m
SOM SomnoMed
1.1x8.62%US$93.87m
SLD Saluda Medical
1.1x37.35%US$84.58m
EBR 30.7xIndustry Avg. 3.5xNo. of Companies17PS0816243240+
17 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: EBR is expensive based on its Price-To-Sales Ratio (30.7x) compared to the Australian Medical Equipment industry average (3.5x).

Price to Sales Ratio vs Fair Ratio

What is EBR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EBR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio30.7x
Fair PS Ratio3.6x

Price-To-Sales vs Fair Ratio: EBR is expensive based on its Price-To-Sales Ratio (30.7x) compared to the estimated Fair Price-To-Sales Ratio (3.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EBR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$0.38
AU$14.04
+3,595.53%
84.37%AU$26.61AU$2.00n/a4
May ’27AU$0.59
AU$23.72
+3,886.27%
9.76%AU$26.16AU$19.92n/a4
Apr ’27AU$0.58
AU$24.08
+4,051.33%
9.61%AU$26.59AU$20.30n/a4
Mar ’27AU$0.73
AU$25.87
+3,419.52%
8.09%AU$29.26AU$24.13n/a4
Feb ’27AU$0.85
AU$25.87
+2,925.55%
8.09%AU$29.26AU$24.13n/a4
Jan ’27AU$0.90
AU$25.87
+2,790.36%
6.92%AU$28.84AU$24.33n/a4
Dec ’26AU$1.02
AU$26.01
+2,450.42%
6.06%AU$28.55AU$24.47n/a4
Nov ’26AU$1.22
AU$24.86
+1,937.34%
8.48%AU$28.35AU$22.71n/a4
Oct ’26AU$1.17
AU$25.88
+2,112.16%
10.70%AU$29.94AU$22.73n/a5
Sep ’26AU$1.23
AU$26.07
+2,028.44%
10.45%AU$29.75AU$22.67n/a5
Aug ’26AU$1.40
AU$25.97
+1,755.10%
10.49%AU$29.78AU$22.49n/a5
Jul ’26AU$1.17
AU$26.70
+2,191.76%
9.89%AU$29.75AU$22.47n/a5
Jun ’26AU$1.11
AU$26.80
+2,314.81%
9.78%AU$29.98AU$22.60AU$0.455
May ’26AU$1.18
AU$28.92
+2,361.24%
11.41%AU$35.08AU$25.48AU$0.595
Apr ’26AU$1.74
AU$28.10
+1,514.82%
17.52%AU$35.33AU$21.54AU$0.584
Mar ’26AU$1.54
AU$19.18
+1,145.58%
12.43%AU$22.77AU$16.52AU$0.734
Feb ’26AU$1.65
AU$19.37
+1,074.20%
11.97%AU$22.58AU$17.15AU$0.853
Jan ’26AU$1.03
AU$18.40
+1,695.17%
11.07%AU$21.20AU$16.41AU$0.903
Dec ’25AU$0.91
AU$18.40
+1,933.20%
11.07%AU$21.20AU$16.41AU$1.023
Nov ’25AU$1.01
AU$18.40
+1,721.83%
11.07%AU$21.20AU$16.41AU$1.223
Oct ’25AU$0.91
AU$16.83
+1,749.96%
14.33%AU$20.24AU$14.99AU$1.173
Sep ’25AU$1.12
AU$16.61
+1,382.68%
13.03%AU$19.66AU$15.00AU$1.233
Aug ’25AU$1.15
AU$14.51
+1,167.22%
6.01%AU$15.66AU$13.56AU$1.403
Jul ’25AU$1.04
AU$14.33
+1,278.15%
7.36%AU$15.65AU$13.06AU$1.173
Jun ’25AU$1.10
AU$14.33
+1,202.98%
7.36%AU$15.65AU$13.06AU$1.113
AU$14.04
Fair Value
97.3% undervalued intrinsic discount
4
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/05 22:37
End of Day Share Price 2026/06/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EBR Systems, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chris SavageBell Potter
John HesterBell Potter
Martyn JacobsBell Potter